EIM
HAE icon

Essex Investment Management’s Haemonetics HAE Stock Holding History

Essex Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-287
Closed -$22.4K – 313
2024
Q4 		$22.4K Sell
287
-410
-59% -$32.9K ﹤0.01% 283
2024
Q3 		$56K Hold
697
– – 0.01% 253
2024
Q2 		$57.7K Sell
697
-96
-12% -$8.45K 0.01% 251
2024
Q1 		$67.7K Sell
793
-319
-29% -$25K 0.01% 244
2023
Q4 		$95.1K Sell
1,112
-10,096
-90% -$873K 0.02% 246
2023
Q3 		$1M Buy
11,208
+1,208
+12% +$108K 0.16% 200
2023
Q2 		$851K Buy
+10,000
New +$845K 0.12% 224

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Essex Investment Management's HAE Position: Q1 2025 in Review

Essex Investment Management sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 287 shares — an estimated $22.4K sold.

Essex Investment Management first reported a position in HAE in Q2 2023 and held it in 7 quarters. The position peaked at $1M in Q3 2023. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Essex Investment Management reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • Essex Investment Management sold 287 Haemonetics shares in Q1 2025, an estimated $22.4K.
  • Essex Investment Management first reported a position in Haemonetics in Q2 2023 and held it in 7 quarters.
  • Essex Investment Management's Haemonetics position peaked at $1M in Q3 2023.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Essex Investment Management's 13F filing for Q1 2025, filed 7 May 2025.